246 related articles for article (PubMed ID: 37958776)
1. Role of UBE2C in Brain Cancer Invasion and Dissemination.
Domentean S; Paisana E; Cascão R; Faria CC
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958776
[TBL] [Abstract][Full Text] [Related]
2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
3. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
4. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
Shuliang S; Lei C; Guangwu J; Changjie L
Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
[TBL] [Abstract][Full Text] [Related]
6. UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines.
Palumbo A; Da Costa NM; De Martino M; Sepe R; Pellecchia S; de Sousa VP; Nicolau Neto P; Kruel CD; Bergman A; Nasciutti LE; Fusco A; Pinto LF
Oncotarget; 2016 Oct; 7(40):65876-65887. PubMed ID: 27588470
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma.
Ong KH; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Chan TC; Li CF; Kuo YH
Eur J Med Res; 2023 Dec; 28(1):593. PubMed ID: 38102624
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.
Hao Z; Zhang H; Cowell J
Tumour Biol; 2012 Jun; 33(3):723-30. PubMed ID: 22170434
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.
Kariri Y; Toss MS; Alsaleem M; Elsharawy KA; Joseph C; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2022 Apr; 192(3):529-539. PubMed ID: 35124721
[TBL] [Abstract][Full Text] [Related]
10.
Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C; Powell C; Yao M; Wu J; Dong Q
Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
[TBL] [Abstract][Full Text] [Related]
12. Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.
Li J; Zhi X; Shen X; Chen C; Yuan L; Dong X; Zhu C; Yao L; Chen M
Biochem Biophys Res Commun; 2020 Mar; 523(2):434-440. PubMed ID: 31875843
[TBL] [Abstract][Full Text] [Related]
13. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
Ieta K; Ojima E; Tanaka F; Nakamura Y; Haraguchi N; Mimori K; Inoue H; Kuwano H; Mori M
Int J Cancer; 2007 Jul; 121(1):33-8. PubMed ID: 17354233
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target.
Huang GZ; Chen ZQ; Wu J; Shao TR; Zou C; Ai YL; Lv XZ
J Immunol Res; 2021; 2021():9250207. PubMed ID: 34950739
[TBL] [Abstract][Full Text] [Related]
15. UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.
Morikawa T; Kawai T; Abe H; Kume H; Homma Y; Fukayama M
Int J Clin Exp Pathol; 2013; 6(7):1367-74. PubMed ID: 23826418
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
[TBL] [Abstract][Full Text] [Related]
17. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.
Guo L; Ding Z; Huang N; Huang Z; Zhang N; Xia Z
Cell Cycle; 2017 Sep; 16(18):1705-1718. PubMed ID: 28767320
[TBL] [Abstract][Full Text] [Related]
18. UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion.
Ma S; Chen Q; Li X; Fu J; Zhao L
Sci Rep; 2023 Oct; 13(1):16899. PubMed ID: 37803076
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract][Full Text] [Related]
20. UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis.
Zhou Y; Zhang J; Gong J; Tang X; Zhang C
Aging (Albany NY); 2022 Sep; 14(17):7003-7013. PubMed ID: 36069832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
